organization

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

24 projects, page 1 of 5
  • project . 2020 - 2022
    Funder: EC Project Code: 101003544
    Overall Budget: 2,547,150 EURFunder Contribution: 2,547,150 EUR
    Open Access mandate for Publications
    Partners: ICN2, UB, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, AMU

    The recent outbreak in China caused by the emerging nCoV virus is challenging the level of global readiness from governments, public organizations and community to face and manage both its social and health consequences. Once the emergence is recognized and identified, ...

  • project . 2015 - 2017
    Funder: EC Project Code: 115844
    Overall Budget: 2,260,100 EURFunder Contribution: 2,260,100 EUR
    Open Access mandate for Publications
    Partners: Mendelova univerzita v Brne, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, GNA BIOSOLUTIONS GMBH, EMERGENCY ONG ONLUS

    There is an urgent need for fast and accurate diagnostic tests in the current Ebola crisis. The rapid diagnosis of EVD during early and late stage of infection is a decisive step for risk assessment and for guidance to physicians to take the necessary decisions to limit...

  • project . 2020 - 2024
    Funder: EC Project Code: 101005111
    Overall Budget: 3,747,600 EURFunder Contribution: 3,435,100 EUR
    Open Access mandate for Publications
    Partners: AIT, GNA BIOSOLUTIONS GMBH, BMVg, MicroLIQUID (Spain), Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

    The DECISION consortium is developing a new class of diagnostic platform that will transform the fight against pandemics. The low-cost, miniaturised, disposable molecular diagnostic platform will allow for patient testing virtually anywhere, within a few minutes, with l...

  • project . 2020 - 2022
    Funder: EC Project Code: 101005075
    Overall Budget: 1,819,960 EURFunder Contribution: 784,470 EUR
    Open Access mandate for Publications
    Partners: AMU, UNIVERSITA DI CORSICA PASQUALE PAOLI, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, BG Research Ltd, BIOTRONICS LTD

    This project focuses on rapid (40min), simple, Point-of-Need COVID-19 testing, e.g. surgery/home (via first responders)/transit points of entry. BG Research (BGR) has developed direct from crude sample detection of viral pathogens – the QuRapID-XF technology, removing r...

  • project . 2017 - 2020
    Funder: EC Project Code: 768889
    Overall Budget: 3,858,770 EURFunder Contribution: 3,858,770 EUR
    Open Access mandate for Publications
    Partners: MultiD Analyses (Sweden), DODOMA REGION, Tataa Biocenter (Sweden), GNA BIOSOLUTIONS GMBH, FHG, LU, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

    The overall goal of this project is to bring the unique, ultra-fast Local Heating PCR technology and its current lab-proven prototype instruments from TRL 4 up to TRL 6 into clinical demonstration in tuberculosis centers in Italy, Latvia, and Tanzania. This will imply a...

24 projects, page 1 of 5
Any information missing or wrong?Report an Issue